Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.

Demircan N., Dane F., Ozturk M. A., Besiroglu M., Babacan N., Kaya S., ...More

53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 35
  • Doi Number: 10.1200/jco.2017.35.15_suppl.e15009
  • City: Illinois
  • Country: United States Of America
  • Marmara University Affiliated: Yes